Skip to content
TrialScanner

NCT04655248

ACURATE neo2™ Post Market Clinical Follow up Study

No phase registeredActive, not recruitingBSXLead

Registry record

Lead sponsor
Boston Scientific Corporation
Conditions
Aortic Valve Stenosis; Aortic Valve Calcification; Aortic Diseases
Primary completion
Mar 9, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04655248 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04655248: ACURATE neo2™ Post Market... | TrialScanner